Tiffani Cuyler v. HHS - MMR, Guillain-Barré syndrome (GBS) (2023)
Case summary [AI summaries can sometimes make mistakes]
Tiffani Cuyler filed a petition for compensation on August 4, 2020, alleging that the measles mumps rubella (MMR) vaccine she received on August 4, 2017, caused her to develop Guillain-Barré syndrome (GBS). She also received a tetanus, diphtheria, acellular pertussis (Tdap) vaccine on June 30, 2017, prior to the onset of her alleged injuries.
Petitioner claimed to have experienced residual effects of her injury for more than six months. Respondent denied that the MMR and/or Tdap vaccines caused Petitioner's GBS or current condition.
However, on December 14, 2022, the parties filed a stipulation agreeing that compensation should be awarded. Special Master Herbrina Sanders found the stipulation reasonable and adopted it as the decision of the Court.
Petitioner was awarded a lump sum of $70,000.00 for all damages, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was posted on the website of the United States Court of Federal Claims.
Theory of causation
Petitioner Tiffani Cuyler alleged that the MMR vaccine administered on August 4, 2017, caused her Guillain-Barré syndrome (GBS). She also received a Tdap vaccine on June 30, 2017. Petitioner alleged residual effects for more than six months. Respondent denied causation. The parties filed a stipulation for award on December 14, 2022. Petitioner was awarded $70,000.00 as a lump sum for all damages. The public decision does not detail the specific theory of causation, medical experts, onset, symptoms, tests, treatments, or the mechanism of injury. Special Master Herbrina Sanders adopted the stipulation as the Court's decision.
Source PDFs
USCOURTS-cofc-1_20-vv-00971